GlassScriptPhysician profile
Jennifer Moebes
NPI 1861863888
$821.07
in general payments reported to CMS, 2019-2025
13 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.43 · 2022: $16.41 · 2023: $154 · 2024: $268 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $185.76 | 2024-2025 | Repatha, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $141.20 | 2025 | Rexulti |
| Gilead Sciences, INC. | $123.50 | 2023 | Epclusa |
| Janssen Pharmaceuticals, INC | $116.74 | 2024 | Xarelto |
| Glaxosmithkline, LLC. | $43.79 | 2024 | Trelegy Ellipta |
| Pfizer INC. | $40.07 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $33.66 | 2025 | Airsupra |
| Hologic Sales and Service, LLC | $30.83 | 2022-2025 | Aptima |
| Irhythm Technologies, INC. | $30.58 | 2023 | Zio Xt Patch |
| Abbvie INC. | $22.13 | 2024 | |
| Tris Pharma INC | $21.14 | 2024 | Dyanavel Xr |
| Exact Sciences Corporation | $16.24 | 2025 | Cologuard Collection Kit |
| Genentech USA, INC. | $15.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Moebes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.